Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Sales

Burning Rock Biotech (BNR) EBT Margin: 2020-2025

Historic EBT Margin for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to 12.51%.

  • Burning Rock Biotech's EBT Margin rose 1903.00% to 12.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.78%, marking a year-over-year increase of 6418.00%. This contributed to the annual value of 66.06% for FY2024, which is 5513.00% up from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's EBT Margin is 12.51%, which was down 95.27% from 6.41% recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's EBT Margin registered a high of 6.41% during Q2 2025, and its lowest value of 200.76% during Q2 2022.
  • Moreover, its 3-year median value for EBT Margin was 79.47% (2024), whereas its average is 71.05%.
  • Per our database at Business Quant, Burning Rock Biotech's EBT Margin tumbled by 5,474bps in 2021 and then soared by 11,366bps in 2023.
  • Over the past 5 years, Burning Rock Biotech's EBT Margin (MRQ) stood at 170.71% in 2021, then grew by 10bps to 153.03% in 2022, then rose by 14bps to 131.77% in 2023, then soared by 55bps to 59.22% in 2024, then surged by 79bps to 12.51% in 2025.
  • Its EBT Margin was 12.51% in Q3 2025, compared to 6.41% in Q2 2025 and 9.98% in Q1 2025.